Acetaminophen & Codeine Oral Solution Recalled Due to Unverified Stability
Akorn, Inc. is recalling all lots of Acetaminophen & Codeine Oral Solution because stability studies cannot be completed. The firm ceased operations and cannot verify the medication's potency and safety.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard is inability to verify medication stability through required studies, making this a risk-of-harm situation where actual adverse consequences have not yet been reported.
Plain-English summary
Akorn, Inc. is recalling all lots of Acetaminophen & Codeine Phosphate Oral Solution 120mg/12mg/5mL. This prescription medication is supplied in 473mL bottles and 40-unit-dose cups.
The manufacturer went out of business and cannot complete stability studies required by current Good Manufacturing Practice regulations.
The product was distributed nationwide in the United States and Puerto Rico. All lots are affected. Patients currently taking this medication should contact their healthcare provider or pharmacist about their medication supply.
The recalled product
- Product
- Acetaminophen & Codeine Phosphate Oral Solution 120mg/12mg/5mL, packaged in a) 473mL bottles and b) 40 UD cups, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs
- Manufacturer
- Akorn, Inc.
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Part of a larger recall action
This product is one of 86 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 86 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · unverified stability
See all →- HighLorazepam Injection Recalled Due to Manufacturing Control Deviations
FDA (Drugs) · 2023-06-07
- HighLactulose Solution Recall Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-06-07
- ModerateAcyclovir Oral Suspension Recalled for Manufacturing Practice Deviations
FDA (Drugs) · 2023-06-07
- ModerateAzelastine Hydrochloride Nasal Spray Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Pilocarpine Ophthalmic Solution Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07